Ortho Clinical Diagnostics announced that it has received CE mark for Ortho's VITROS® XT 7600 Integrated System. By combining Ortho's proprietary dry slide technology with sophisticated digital ...

RARITAN, N.J., July 24, 2018 /PRNewswire/ -- Ortho Clinical Diagnostics today announced that it has received CE mark for Ortho's VITROS® XT 7600 Integrated System. By combining Ortho's proprietary dry ...

QuidelOrtho’s infectious disease test portfolio spans the healthcare continuum from point-of-care settings to high-throughput laboratories and is critical in addressing the growing syphilis epidemic ...

QuidelOrtho Corporation QDEL recently announced the addition of the ARK Fentanyl II Assay to its U.S. Vitros XT 7600 and 5600 Integrated Systems as well as its Vitros 4600 Chemistry System menu of ...

RARITAN, N.J., Feb. 26, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today ...

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions, designed to cover most typical lab tests with a smaller footprint ...

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the ...

QuidelOrtho Receives FDA 510(k) Clearance for its VITROS Syphilis Assay SAN DIEGO, August 29, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") has received U.S. Food and ...